United States: Consumer Trading & Unfair Trading

New York and Colorado have updated automatic-renewal laws going into effect later this year and early next year, introducing new compliance obligations for businesses offering subscription services.

The New Jersey Division of Consumer Affairs has issued proposed regulations to further detail and implement the New Jersey Data Privacy Act (NJDPA)—the state's comprehensive...

Welcome to Wiley's update on recent developments and what's next in consumer protection at the Federal Trade Commission (FTC), Consumer Financial Protection Bureau (CFPB), and at the state level.

The New Jersey Division of Consumer Affairs has issued proposed regulations to further detail and implement the New Jersey Data Privacy Act (NJDPA)—the state's comprehensive...

In this episode of "Clearly Conspicuous," consumer protection attorney Anthony DiResta provides an early analysis of the Federal Trade Commission's (FTC) direction under Chair Andrew Ferguson...

One week remains for clients to submit comments in response to review of potential reciprocal tariffs being conducted by the U.S. Trade Representative ("USTR").

POM Wonderful v FTC - Both Sides Claim Victory even though the Court says: "neither side’s position as to the claims made or adequacy of substantiation has been totally vindicated."

On May 30, 2012, the public comment period began for proposed regulations issued by thirteen New York State agencies (including the Department of Health, the Office of Mental Health, and the Office of Children and Family Services) seeking to limit the executive compensation paid by, and administrative costs of, service providers that receive State funding.

On May 21, 2012, the Ninth Circuit Court of Appeals held that because the use of medical marijuana remains illegal under federal law, the Americans with Disabilities Act (ADA) does not protect against discrimination on the basis of medical marijuana use, even if that use is in accordance with state law explicitly authorizing such use.

Congress and FDA lauded the Modernization of Cosmetics Regulation Act (MoCRA), enacted in 2022, as sweeping federal legislation to increase cosmetic safety and quality standards.

The Supreme Court of Appeals of West Virginia declined to decide whether West Virginia allows for public nuisance claims against distributors of prescription opioids.

In part two of this three-part series on the Attorney General Alliance (AGA) 2025 Annual Meeting, we highlight panelists' discussions on the safety and regulation of GLP-1...